PharmTech Europe, Weekly Alert
Having trouble viewing this e-mail? CLICK HERE

PharmTech Europe
14 August 2018

PHARMTECH.COM

CURRENT ISSUE

SUBSCRIBE

FORWARD

twitter twitter
advertisement

Top Stories

EMA Scales Back Activities to Prepare for Brexit

The European Medicines Agency will temporarily scale back activities as it copes with "significant staff loss" and prepares for the next phase in its continuity plan.
/ read more /


Ebola Vaccinations Begin in Response to Congo's Last Outbreak

Ebola vaccinations by the World Health Organization began in North Kivu, Democratic Republic of the Congo, one week after the country's latest outbreak.
/ read more /

Subscribe

Subscribers can enjoy each full issue of Pharm Tech Europe in print, or via Pharm Tech Europe apps.

subscription offers
subscribe
advertisement

Industry News

AuroMedics Pharma Issues Voluntary Recall Due to Glass and Silicone Particulates

AuroMedics Pharma issued a voluntary, nationwide recall of two lots of piperacillin and tazobactam for injection, USP 3.375 g due to the presence of particulates identified as glass and silicone material.
/ read more /


Diabetes Drugs Shown to Help Macrophages Control Inflammation

Researchers at the University of Pennsylvania found that diabetes drugs called thiazolidinediones can promote the metabolism of glutamine to help control disease-causing inflammation.
/ read more /


More Industry News
advertisement

Regulatory News

EMA Recommends Sixteen Medicines for Approval

The recommended drugs include two orphan medicines and three biosimilars.
/ read more /


FDA Publishes Guidance on Developing New Treatments for Opioid Use Disorder

The agency issued a draft guidance on developing new medication-assisted treatments for opioid-use disorder.
/ read more /


More Regulatory News

Bio/Pharma News

Bayer to Sell Prescription Dermatology Unit

Denmark-headquartered pharmaceutical company LEO Pharma is set to acquire Bayer's prescription treatment portfolio.
/ read more /


EC Approves Pfizer's Biosimilar to Roche's Herceptin

The European Commission (EC) approved Pfizer's Trazimera (trastuzumab), a biosimilar to Roche's Herceptin, to treat certain breast and gastric cancers.
/ read more /


More Bio/Pharma News

Supplier News

Key Biologics and Astarte Biologics Merge

The combined companies will provide research- and clinical-grade human immune cells, blood products, and related services.
/ read more /


 

MilliporeSigma, InnoCore to Partner on Biodegradable Drug Delivery Platform

The companies will collaborate to bring InnoCore Pharmaceuticals' proprietary SynBiosys biodegradable polymer platform to market.
/ read more /


More Supplier News

FEATURED TOPICS

OUTSOURCING

Reducing Development Timelines and Costs

Joe DiMasi, director of economic analysis and research associate professor, Tufts Center for the Study of Drug Development (CSDD), discussed research into the impacts of working with single source contractors.
/ read more /

 

DRUG DEVELOPMENT

Innovating Lifecycle Management with Data-Driven and Enabling Technologies

Pharmaceutical companies are developing new strategies to address the increasing development costs for new drug therapies and maximize the value of their existing drug portfolio.
/ read more /

FORMULATION

Developing Capsules for DPIs

Formulation characteristics must be optimized, following device selection, to achieve the desired performance for the capsule loaded in the dry powder inhaler.
/ read more /

REGULATORY WATCH

Collaboration on GMP Inspections Has Been Successful but Challenges Exist

EMA, the leading driver behind GMP inspection collaboration schemes, will be cutting back its involvement because of the need to concentrate on its relocation to Amsterdam.
/ read more /


Product Profiles

Lonza Pharma & Biotech

Capsugel® Vcaps® Enteric
Due to the intrinsic enteric properties of Capsugel® Vcaps® Enteric, no coating step is needed. It means that this capsule is a ready-to-use solution that can help you in obtaining significant cost and time savings during pharmaceutical development or compounding.
/ Read more/

PDA Europe

PDA Pharmaceutical Microbiology Conference
The PDA Pharmaceutical Microbiology conference will take place 15-16 October 2018 and it will be a truly global event: The conference will take place simultaneously in Berlin, Germany and Bethesda, USA.
/ Read more/


Events

SMi's 9th Annual Biosimilars & Biobetters Conference

London, United Kingdom

26–27 September 2018

CPhI 2018

Madrid, Spain

9–11 October 2018

Cell & Gene Therapy 2018

London, United Kingdom

10–11 October 2018

PDA Europe Pharmaceutical Microbiology

Berlin, Germany

15–16 October 2018


more events

eBOOKS

Biologics and Sterile Drug Manufacturing 2018

This ebook covers novel technologies for the formulation, manufacture, purification, and delivery of sterile small- and large-molecule drugs, including single-use systems, facilities and equipment, contamination issues, and process analytics.

contribute | CONTACT EDITORS | CONTACT SALES | subscribe | advertise